Cheng, M.
Roseberry, K.
Choi, Y.
Quast, L.
Gaines, M.
Sandusky, G.
Kline, J. A.
Bogdan, P.
Niculescu, A. B.
Funding for this research was provided by:
National Institute of Mental Health (R01MH117431)
U.S. Department of Veterans Affairs (2I01CX000139)
Article History
Received: 11 March 2022
Accepted: 24 May 2022
First Online: 13 June 2022
Declarations
:
: The original study was reviewed and approved by the Indiana University School of Medicine Institutional Review Board (IRB) (study number 2012150820). All participants signed informed consents, which included consent to be followed-up. This study was conducted as a follow-up study, separate ethical approval was waived by the Indiana University School of Medicine Institutional Review Board (IRB) in view of the EMR retrospective nature of the study. All follow-up was done via electronic medical record (EMR) review rather than direct patient interview. Thus data related to suicidality was obtained from EMR-documented outpatient visits and emergency department visits, where patients were assessed at that time and triaged by mental health and/or emergency department providers if showing signs of suicidality, using the current standard of care.
: ABN is listed as inventor on a patent application filed by Indiana University on suicidality risk prediction, and is a co-founder of MindX Sciences.